BioTechGrid – Page 349

Engitix Licenses Lonza’s Technology to Advance ADC Therapies

July 22, 2026

Credit: Sanjeri/Getty Images Lonza and Engitix signed a licensing agreement to advance the development of antibody-drug conjugates (ADCs) as therapies…

Research

House passes bill directing FDA to update animal testing rules

July 22, 2026

The U.S. House of Representatives passed the FDA Modernization Act 3.0 this week, and lawmakers and animal welfare advocates are…

Biotechnology

Royalty Pharma pens $425M deal for slice of sales on AstraZeneca’s ATTR drug

July 22, 2026

Royalty Pharma has secured a stake in another transthyretin-mediated amyloidosis drug, this time paying $125 million upfront to Neurimmune for…

Biotechnology

Celldex ends skin disease program after failing phase 2 test

July 22, 2026

A phase 2 study of Celldex’s barzolvolimab in a chronic skin disease has missed its primary endpoint, driving the biotech…

Genetics

UCSD, IGI Partnership Expands CRISPR Innovation Across Health, Agriculture, and the Environment

July 22, 2026

California may be known as the Golden State, but it may well be referred to as the Genome Editing state…

Biotechnology

‘We’re moving quickly’: Startup bags rare disease drug as Thiel-backed CEO eyes $50M fundraise

July 21, 2026

A rare disease startup with a mission to repurpose proven drugs has licensed a Chinese formulation of a well-known medicine…

Biotechnology

Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challenge

July 21, 2026

A group of 61 biopharma companies, executives and investors has filed an amicus brief in support of the FDA in…

Genetics

10x Clinical Expansion Advances with CLIA Lab Plans, Cleveland Clinic Partnership

July 21, 2026

A researcher at work at Cleveland Clinic’s Pathology and Laboratory Medicine Institute. 10x Genomics is partnering with Cleveland Clinic in…

Genetics

Blood Cancer Therapies Informed by Spatial Remodeling of Bone Marrow

July 21, 2026

Cancer cells in blood [wildpixel / iStock / Getty Images Plus] In a new study published in Leukemia titled, “Spatial remodeling of bone…

Biotechnology

Crystalys mines $130M series B to push gout drug through phase 3

July 21, 2026

Crystalys Therapeutics has raised $130 million in series B financing to advance the development of its gout drug dotinurad and…

Saharan Dust Storm Rained Tiny Mineral Spheres on Switzerland for the First Time

Deep Learning Meets Blockchain: VoteChain Slashes Energy Use in Financial Consensus

First Plasmid Found in Halovibrio Reveals a Mosaic Genome Forged by Gene-Sharing in Salt Brines

Semaglutide Delivers 14–17% Weight Loss in Landmark Review, but Gains Fade After Stopping

AI Learns to Summarize Conversations Without Annotated Examples Using Bridge Domains

Light-powered nanozymes promise programmable catalysis, from cancer therapy to clean water

Exploring the Future of Healthcare with Panos Karelis

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

Engitix Licenses Lonza’s Technology to Advance ADC Therapies

House passes bill directing FDA to update animal testing rules

Royalty Pharma pens $425M deal for slice of sales on AstraZeneca’s ATTR drug

Celldex ends skin disease program after failing phase 2 test

UCSD, IGI Partnership Expands CRISPR Innovation Across Health, Agriculture, and the Environment

‘We’re moving quickly’: Startup bags rare disease drug as Thiel-backed CEO eyes $50M fundraise

Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challenge

10x Clinical Expansion Advances with CLIA Lab Plans, Cleveland Clinic Partnership

Blood Cancer Therapies Informed by Spatial Remodeling of Bone Marrow

Crystalys mines $130M series B to push gout drug through phase 3

VertigoDx on firm ground with FDA greenlight for vertigo diagnostic system

Precision Neuroscience taps $250M in Series D funding for brain-computer interface

VC Sofinnova reels in €82M to target medtechs in the next 5 years

Adagio Medical kicks off strategic review, trims more than half its staff